Iovance Biotherapeutics Inc (IOVA)
EBITDA Growth
59.13%
Quarterly · Period ending:
IOVA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported59.13%period ending
Latest reported59.13%period ending
IOVA Quarterly EBITDA YoY % (74.85% → 59.13%)
Year-over-year change
High-resolution chart · PNG
IOVA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 59.1293% | |
| 35.9592% | |
| 6.8867% | |
| -0.412% | |
| -15.7957% | |
| -5.5601% | |
| 39.7606% | |
| 25.8818% | |
| 11.5657% | |
| -2.7579% | |
| -8.8463% | |
| -11.3455% | |
| -5.3804% | |
| -17.366% | |
| -14.3441% | |
| -14.9214% | |
| -19.761% | |
| -19.0024% | |
| -32.7179% | |
| -40.0586% | |
| -23.9983% | |
| -3.1719% | |
| -1.2713% | |
| -14.3539% | |
| -27.0491% | |
| -77.6608% | |
| -86.8381% | |
| -47.3642% | |
| -60.1002% | |
| -49.03% | |
| -34.3103% | |
| -57.5282% | |
| -33.4862% | |
| -28.9821% | |
| -67.7317% | |
| -17.3437% | |
| -103.7186% | |
| -206.4976% | |
| -89.0376% | |
| -155.2318% | |
| -84.7742% | |
| -31.8404% | |
| -69.6023% | |
| -163.6932% | |
| -193.9782% | |
| -127.9536% | |
| 58.2166% | |
| 70.2567% | |
| 36.5523% | |
| -219.0612% | |
| -306.7074% | |
| -1,626.055% | |
| -1,274.6953% | |
| 87.6298% | |
| 238.1615% | |
| 90.5513% | |
| 102.6839% | |
| -787.9688% | |
| -818.9498% | |
| -3,402.1038% | |
| -12,357.9045% | |
| -845.6265% | |
| -21,669.3837% | |
| -5,150.271% | |
| -2,709.7278% | |
| -977.8786% | |
| 85.6337% | |
| -46.7259% | |
| 79.513% | |
| 74.8468% |